Teva buys Mexico’s Rimsa for US$2.3 billion

Israeli pharmaceuticals company Teva has purchased Mexican counterpart Rimsa for US$2.3 billion, with the help of Greenberg Traurig LLP in Mexico City, Miami, London and Fort Lauderdale.

Get unlimited access to all Latin Lawyer content